Rita 21 1 tab daily starting on 1st day of menstruation for 21 consecutive days; subsequent courses repeated after 7-day interval. Rita 28 1 tab daily for 21 consecutive days starting on 1st day of menstruation, followed by inert tab for 7 days. Each subsequent pack is started after a 7-day tab-free interval. As w/drawal bleeding occurs w/in 2 or 3 days after the last hormonally active tab, start a new course of 28-day regimen whether bleeding has stopped or not.
Increased risk of serious CV effects & cerebrovascular diseases (especially hypertensive) in women smokers >35 yr; MI in smokers or women w/ other underlying risk factors for CAD eg, HTN, hypercholesterolemia, morbid obesity & diabetes. Discontinue if thromboembolic & thrombotic disorders occurs. Monitor women during treatment & re-examine at least once a yr especially those w/ strong family history of breast cancer or who have breast nodules, fibrocystic disease of the breast, cervical dysplasia or abnormal mammograms. Carefully monitor pre-diabetic & diabetic patients during estrogen-progestin contraceptive therapy. Lactation.
G03AA09 - desogestrel and ethinylestradiol ; Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
Sign Out
